CN105341944A - 一种提高免疫力的丹参口服液及其制备方法 - Google Patents
一种提高免疫力的丹参口服液及其制备方法 Download PDFInfo
- Publication number
- CN105341944A CN105341944A CN201510855905.1A CN201510855905A CN105341944A CN 105341944 A CN105341944 A CN 105341944A CN 201510855905 A CN201510855905 A CN 201510855905A CN 105341944 A CN105341944 A CN 105341944A
- Authority
- CN
- China
- Prior art keywords
- parts
- red sage
- sage root
- salvia miltiorrhiza
- oral liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000036039 immunity Effects 0.000 title claims abstract description 46
- 239000007788 liquid Substances 0.000 title claims abstract description 25
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title claims description 18
- 241000304195 Salvia miltiorrhiza Species 0.000 title abstract 6
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 33
- 244000197580 Poria cocos Species 0.000 claims abstract description 18
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 18
- 239000002994 raw material Substances 0.000 claims abstract description 16
- 240000006079 Schisandra chinensis Species 0.000 claims abstract description 15
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 14
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 14
- 241000830535 Ligustrum lucidum Species 0.000 claims abstract description 13
- 244000269722 Thea sinensis Species 0.000 claims abstract description 12
- 240000007164 Salvia officinalis Species 0.000 claims description 54
- 239000003814 drug Substances 0.000 claims description 53
- 235000005412 red sage Nutrition 0.000 claims description 53
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 43
- 239000000284 extract Substances 0.000 claims description 30
- 230000036541 health Effects 0.000 claims description 22
- 238000010438 heat treatment Methods 0.000 claims description 21
- 230000008901 benefit Effects 0.000 claims description 17
- 241000756943 Codonopsis Species 0.000 claims description 15
- 229940079593 drug Drugs 0.000 claims description 15
- 241000132012 Atractylodes Species 0.000 claims description 14
- 244000132619 red sage Species 0.000 claims description 14
- 241000208966 Polygala Species 0.000 claims description 13
- 240000002853 Nelumbo nucifera Species 0.000 claims description 12
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 12
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 12
- 241000218989 Trichosanthes Species 0.000 claims description 12
- 238000000605 extraction Methods 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 12
- 240000002948 Ophiopogon intermedius Species 0.000 claims description 11
- 235000012907 honey Nutrition 0.000 claims description 10
- 238000000108 ultra-filtration Methods 0.000 claims description 10
- 230000002829 reductive effect Effects 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 7
- 239000006228 supernatant Substances 0.000 claims description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 6
- 238000005202 decontamination Methods 0.000 claims description 5
- 230000003588 decontaminative effect Effects 0.000 claims description 5
- 235000011837 pasties Nutrition 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 4
- 230000000844 anti-bacterial effect Effects 0.000 claims description 4
- 238000010992 reflux Methods 0.000 claims description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 244000025254 Cannabis sativa Species 0.000 claims description 3
- 229920001353 Dextrin Polymers 0.000 claims description 3
- 239000004375 Dextrin Substances 0.000 claims description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- 230000001976 improved effect Effects 0.000 claims description 3
- 229910052742 iron Inorganic materials 0.000 claims description 3
- 238000002386 leaching Methods 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 238000005057 refrigeration Methods 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 230000006837 decompression Effects 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 238000001802 infusion Methods 0.000 claims description 2
- 238000004064 recycling Methods 0.000 claims description 2
- 238000012216 screening Methods 0.000 claims description 2
- 238000000926 separation method Methods 0.000 claims description 2
- 238000007873 sieving Methods 0.000 claims description 2
- 238000002791 soaking Methods 0.000 claims description 2
- 239000007858 starting material Substances 0.000 claims description 2
- 238000000967 suction filtration Methods 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 29
- 210000004369 blood Anatomy 0.000 abstract description 27
- 230000006870 function Effects 0.000 abstract description 14
- 208000002173 dizziness Diseases 0.000 abstract description 12
- 230000001737 promoting effect Effects 0.000 abstract description 10
- 235000019640 taste Nutrition 0.000 abstract description 10
- 208000009205 Tinnitus Diseases 0.000 abstract description 9
- 231100000886 tinnitus Toxicity 0.000 abstract description 9
- 230000017531 blood circulation Effects 0.000 abstract description 7
- 201000001881 impotence Diseases 0.000 abstract description 7
- 230000027939 micturition Effects 0.000 abstract description 7
- 244000077995 Coix lacryma jobi Species 0.000 abstract description 4
- 208000008967 Enuresis Diseases 0.000 abstract description 4
- 208000006820 Arthralgia Diseases 0.000 abstract description 3
- 208000024891 symptom Diseases 0.000 abstract description 3
- 241000405414 Rehmannia Species 0.000 abstract description 2
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract description 2
- 240000001341 Reynoutria japonica Species 0.000 abstract description 2
- 206010047513 Vision blurred Diseases 0.000 abstract description 2
- 206010036596 premature ejaculation Diseases 0.000 abstract description 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 2
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241000092665 Atractylodes macrocephala Species 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 241000759833 Cornus officinalis Species 0.000 abstract 1
- 244000084791 Curculigo orchioides Species 0.000 abstract 1
- 244000248557 Ophiopogon japonicus Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 241001080798 Polygala tenuifolia Species 0.000 abstract 1
- 235000008422 Schisandra chinensis Nutrition 0.000 abstract 1
- 206010041497 Spermatorrhoea Diseases 0.000 abstract 1
- 240000006023 Trichosanthes kirilowii Species 0.000 abstract 1
- 235000009818 Trichosanthes kirilowii Nutrition 0.000 abstract 1
- 239000000853 adhesive Substances 0.000 abstract 1
- 230000001070 adhesive effect Effects 0.000 abstract 1
- 208000024765 knee pain Diseases 0.000 abstract 1
- 230000009978 visual deterioration Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 34
- 210000003734 kidney Anatomy 0.000 description 33
- 201000010099 disease Diseases 0.000 description 32
- 230000000694 effects Effects 0.000 description 23
- 230000007812 deficiency Effects 0.000 description 21
- 210000004072 lung Anatomy 0.000 description 21
- 210000000952 spleen Anatomy 0.000 description 21
- 210000004185 liver Anatomy 0.000 description 16
- 235000013305 food Nutrition 0.000 description 15
- 206010011224 Cough Diseases 0.000 description 14
- 208000002193 Pain Diseases 0.000 description 12
- 235000009508 confectionery Nutrition 0.000 description 12
- 206010062717 Increased upper airway secretion Diseases 0.000 description 11
- 208000026435 phlegm Diseases 0.000 description 11
- 230000035922 thirst Effects 0.000 description 11
- 206010012735 Diarrhoea Diseases 0.000 description 10
- 230000009286 beneficial effect Effects 0.000 description 10
- 230000000306 recurrent effect Effects 0.000 description 10
- 206010037660 Pyrexia Diseases 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 9
- 206010033557 Palpitations Diseases 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 238000011282 treatment Methods 0.000 description 8
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 7
- 210000001015 abdomen Anatomy 0.000 description 7
- 206010022437 insomnia Diseases 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 206010049865 Achromotrichia acquired Diseases 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 230000035619 diuresis Effects 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 210000000987 immune system Anatomy 0.000 description 6
- 208000033065 inborn errors of immunity Diseases 0.000 description 6
- 210000003127 knee Anatomy 0.000 description 6
- 244000000010 microbial pathogen Species 0.000 description 6
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 6
- 238000010791 quenching Methods 0.000 description 6
- 238000005728 strengthening Methods 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 5
- 206010038743 Restlessness Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 210000000988 bone and bone Anatomy 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 231100000862 numbness Toxicity 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 210000001835 viscera Anatomy 0.000 description 5
- 206010046788 Uterine haemorrhage Diseases 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 208000031971 Yin Deficiency Diseases 0.000 description 4
- 230000000259 anti-tumor effect Effects 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 235000013339 cereals Nutrition 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- 230000002269 spontaneous effect Effects 0.000 description 4
- 239000011800 void material Substances 0.000 description 4
- 230000008673 vomiting Effects 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 206010013954 Dysphoria Diseases 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 240000005373 Panax quinquefolius Species 0.000 description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 description 3
- 208000001431 Psychomotor Agitation Diseases 0.000 description 3
- 230000001147 anti-toxic effect Effects 0.000 description 3
- 208000017574 dry cough Diseases 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 210000005229 liver cell Anatomy 0.000 description 3
- 206010029410 night sweats Diseases 0.000 description 3
- 230000036565 night sweats Effects 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 239000000932 sedative agent Substances 0.000 description 3
- 230000001624 sedative effect Effects 0.000 description 3
- 235000015096 spirit Nutrition 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- 235000002722 Dioscorea batatas Nutrition 0.000 description 2
- 235000006536 Dioscorea esculenta Nutrition 0.000 description 2
- 240000001811 Dioscorea oppositifolia Species 0.000 description 2
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 description 2
- 206010013789 Dry throat Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 206010019909 Hernia Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 235000015468 Lycium chinense Nutrition 0.000 description 2
- 244000241872 Lycium chinense Species 0.000 description 2
- 208000037093 Menstruation Disturbances Diseases 0.000 description 2
- 206010027339 Menstruation irregular Diseases 0.000 description 2
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 2
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 206010035664 Pneumonia Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 241000593989 Scardinius erythrophthalmus Species 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- HLXRWTJXGMHOFN-XJSNKYLASA-N Verbenalin Chemical compound O([C@@H]1OC=C([C@H]2C(=O)C[C@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HLXRWTJXGMHOFN-XJSNKYLASA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000003905 agrochemical Substances 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000003542 behavioural effect Effects 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 208000013116 chronic cough Diseases 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000007123 defense Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000003337 fertilizer Substances 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 150000008131 glucosides Chemical class 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 235000021142 long-term diet Nutrition 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000004630 mental health Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000036651 mood Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 229940100243 oleanolic acid Drugs 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 235000021179 potluck Nutrition 0.000 description 2
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000003716 rejuvenation Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- JVXZRQGOGOXCEC-UHFFFAOYSA-N scutellarein Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C(O)=C(O)C=C2O1 JVXZRQGOGOXCEC-UHFFFAOYSA-N 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 208000019116 sleep disease Diseases 0.000 description 2
- 208000020685 sleep-wake disease Diseases 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 206010044008 tonsillitis Diseases 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 230000004304 visual acuity Effects 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 210000004916 vomit Anatomy 0.000 description 2
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000242 Abortion threatened Diseases 0.000 description 1
- 244000205574 Acorus calamus Species 0.000 description 1
- 241001412627 Adenophora liliifolia Species 0.000 description 1
- 244000296912 Ageratum conyzoides Species 0.000 description 1
- 235000004405 Ageratum conyzoides Nutrition 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000037259 Amyloid Plaque Diseases 0.000 description 1
- 206010002368 Anger Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 244000252230 Artemisia stelleriana Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 235000011996 Calamus deerratus Nutrition 0.000 description 1
- 235000016535 Capraria biflora Nutrition 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 241000606161 Chlamydia Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- UGWAFWFSLCHCJD-UHFFFAOYSA-N Cornuside Natural products OC1C(O)C(O)C(CO)OC1OC1C(C=C)C(CCOC(=O)C=2C=C(O)C(O)=C(O)C=2)C(C(O)=O)=CO1 UGWAFWFSLCHCJD-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010052804 Drug tolerance Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010067715 Gastrointestinal sounds abnormal Diseases 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 208000008899 Habitual abortion Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- AMBQHHVBBHTQBF-UHFFFAOYSA-N Loganin Natural products C12C(C)C(O)CC2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O AMBQHHVBBHTQBF-UHFFFAOYSA-N 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
- 235000019082 Osmanthus Nutrition 0.000 description 1
- 241000333181 Osmanthus Species 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 241000287127 Passeridae Species 0.000 description 1
- 241000756042 Polygonatum Species 0.000 description 1
- 235000008737 Polygonatum biflorum Nutrition 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 240000004980 Rheum officinale Species 0.000 description 1
- 235000008081 Rheum officinale Nutrition 0.000 description 1
- 235000017276 Salvia Nutrition 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 208000006268 Sarcoma 180 Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- VSJGJMKGNMDJCI-ZASXJUAOSA-N Sweroside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](C=C)[C@H](CCOC2=O)C2=CO1 VSJGJMKGNMDJCI-ZASXJUAOSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000005985 Threatened Abortion Diseases 0.000 description 1
- 206010043866 Tinea capitis Diseases 0.000 description 1
- HLXRWTJXGMHOFN-UHFFFAOYSA-N Verbenalin Natural products C12C(C)CC(=O)C2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O HLXRWTJXGMHOFN-UHFFFAOYSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010048245 Yellow skin Diseases 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000002058 anti-hyperglycaemic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003262 anti-osteoporosis Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229910052956 cinnabar Inorganic materials 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000003028 elevating effect Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 108010074605 gamma-Globulins Proteins 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000026781 habituation Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229930182489 iridoid glycoside Natural products 0.000 description 1
- 150000008145 iridoid glycosides Chemical class 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 208000013433 lightheadedness Diseases 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- AMBQHHVBBHTQBF-UOUCRYGSSA-N loganin Chemical compound O([C@@H]1OC=C([C@H]2C[C@H](O)[C@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O AMBQHHVBBHTQBF-UOUCRYGSSA-N 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 208000025036 lymphosarcoma Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229940099690 malic acid Drugs 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- SMTKSCGLXONVGL-ZEIULZLQSA-N methyl (2r,3s,4r)-3-ethenyl-4-[2-(3,4,5-trihydroxybenzoyl)oxyethyl]-2-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydro-2h-pyran-5-carboxylate Chemical compound O([C@H]1OC=C([C@@H]([C@@H]1C=C)CCOC(=O)C=1C=C(O)C(O)=C(O)C=1)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SMTKSCGLXONVGL-ZEIULZLQSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000008965 mitochondrial swelling Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 201000005111 ocular hyperemia Diseases 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 238000011127 radiochemotherapy Methods 0.000 description 1
- 230000001603 reducing effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 235000019991 rice wine Nutrition 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000005982 spleen dysfunction Effects 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- VSJGJMKGNMDJCI-QXSNVGMTSA-N sweroside Natural products OC[C@H]1O[C@H](O[C@@H]2OC=C3[C@@H](CCOC3=O)[C@H]2C=C)[C@H](O)[C@@H](O)[C@@H]1O VSJGJMKGNMDJCI-QXSNVGMTSA-N 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 229960001367 tartaric acid Drugs 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 208000009189 tinea favosa Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
Abstract
本发明提供了一种提高免疫力的丹参口服液,其所述丹参保健茶中各种原料的重量份数为:丹参10~50份,薏仁10~20份,当归10~20份,黄精10~20份,山茱萸10~20份,茯苓10~20份,丹参10~20份,党参10~20份,枸杞10~20份,制首乌10~20份,熟地10~20份,白术10~20份,五味子10~20份,女贞子10~20份,远志10~20份,麦冬10~20份,天花粉10~20份,赤芍10~20份,仙茅10~20份。本发明可用于腰膝酸痛、阳痿、早泄、遗精、遗尿、尿频余沥、耳鸣、头眩眼花、视力减退、带下等症。再加上一些活血化瘀,口感清淡中药,不影响口感,使人易于接受,能较好的达到提高免疫力的功效。
Description
技术领域
本发明涉及含有来源于植物组份的保健品,特别涉及一种提高免疫力的丹参口服液及其制备方法。
背景技术
免疫力在人体生命机制中发挥重要的作用,而人体的营养、劳累、心情、环境、疾病、用药、辐射等导致自身的免疫力下降。数百万年来,人类在生活一个既适合生存又充满危险的环境,人类得以存续,也获得了非凡的免疫力。所以说免疫力是生物进化过程的产物。
免疫力低下的身体易于被感染或患癌症。各种原因使免疫系统不能正常发挥保护作用,在此情况下,极易招致细菌、病毒、真菌等感染,因此免疫力低下最直接的表现就是容易生病。因经常患病,加重了机体的消耗,所以一般有体质虚弱、营养不良、精神萎靡、疲乏无力、食欲降低、睡眠障碍等表现,生病、打针吃药便成了家常便饭。每次生病都要很长时间才能恢复,而且常常反复发作。长此以往会导致身体和智力发育不良,还易诱发重大疾病。深层原因是免疫力低下或免疫力不健全。当人体免疫功能失调,或者免疫系统不健全时,下列问题就会反复发作:感冒反复发作、扁桃体炎反复发作、哮喘反复发作、支气管炎反复发作、肺炎反复发作、腹泻反复发作......所以千万不可小视。
通常说的人体免疫力就是指人体的免疫系统抵御外来病原微生物等侵害的能力。在人体免疫力正常的情况下,人体自身能够抵御相当多的病菌的侵害,避免对人体造成损伤。人体免疫是人体对外界的病原微生物等的防御机能,或者说是防御系统,在正常情况下,它能够保证人体不受外界病原微生物的侵害。
免疫力是指机体抵抗外来侵袭,维护体内环境稳定性的能力。空气中充满了各种各样的微生物:细菌、病毒、支原体、衣原体、真菌等等。在人体免疫力低下的情况下,它们都可以成为感早班的病原体。虽然人体对不同的病原体会产生相应的抗体,以抵御再次感染,但抗体具有专一性和时限性,比如链球菌抗体只能在较短时期内保护机体不受链球菌的再次侵犯,也并不能抵御其他病毒的感染。免疫力低下的人根本无法抵御感冒病毒的侵袭,这才是易感人群频繁感冒的真正原因。
由于经济的日益发达,现代人生活水平的不断提升,致使人们过多的热爱享受,不注意自己的生活方式、行为习惯、饮食嗜好,从而引起的疾病。快节奏的社会生活,激烈竞争的工作压力,对现代人的身心健康造成了严重的威胁,使半数以上的人处于亚健康状态,表现为:头晕、心慌、乏力、食欲不振、记忆力减退、失眠、对事无兴趣等,加之,长期的饮食不合理,即:精粮完全取代粗粮,大量的三高(高热、高蛋白、高脂肪)、三多(防腐剂多、增味剂多、激素多)食物的摄入和食物中残留的农药、化肥在体内的存积,再加上空气、水源污染和运动量偏小,这样长期下去会使三高症(高血压、高血糖、高血脂)、心脑血管疾病、癌症等所谓的“现代文明病”急速上升,而且不断年轻化,严重的危害到人类的健康和生命。
现代人选择一些保健食品或功能食品都是为了强身健体。保健品的功能主要是改善人体血液循环,提高人体免疫力。现在市面上出售的各种保健品、药品鱼龙混杂,大多数只是虚假宣传的噱头,有的不仅没有保健成分,还造成人身体的巨大伤害。中药气味清苦,很多人不愿长期服用;即使服用,是药三分毒,让人长期服用时也产生抗拒心理。怎么把丹参的功效发挥到最大又不伤害人体,并且明显改善口感,使人能接受,是我们迫切需要解决的问题。丹参里面含有大量安全有效的活性物质保健品,能大大提高人体免疫力,一直是人们期待解决问题的关键。
发明内容
本发明所要解决的技术问题在于,现在市面上出售的各种保健品、药品鱼龙混杂,大多数只是虚假宣传的噱头,有的不仅没有保健成分,还造成人身体的巨大伤害。中药气味清苦,很多人不愿长期服用;即使服用,是药三分毒,让人长期服用时也产生抗拒心理。丹参味辛甘,性平,入肝、肾二经。具有补肾益精、养肝明目、安胎的功效。可用于腰膝酸痛、阳痿、早泄、遗精、遗尿、尿频佘沥、耳鸣、头眩眼花、视力减退、先兆流产、带下等症。再加上一些活血化瘀,口感清淡中药,不影响口感,使人易于接受,能较好的达到提高免疫力的功效。
为解决上述技术难题,本发明提供一种提高免疫力的丹参口服液,其所述丹参保健茶中各种原料的重量份数为:丹参10~50份,薏仁10~20份,当归10~20份,黄精10~20份,山茱萸10~20份,茯苓10~20份,丹参10~20份,党参10~20份,枸杞10~20份,制首乌10~20份,熟地10~20份,白术10~20份,五味子10~20份,女贞子10~20份,远志10~20份,麦冬10~20份,天花粉10~20份,赤芍10~20份,仙茅10~20份。
所述提高免疫力的丹参口服液,其所述丹参保健茶中各种原料的重量份数可以为:丹参10~30份,薏仁10~15份,当归10~15份,黄精10~15份,山茱萸10~15份,茯苓10~15份,丹参10~15份,党参10~15份,枸杞10~15份,制首乌10~15份,熟地10~20份,白术10~20份,五味子10~20份,女贞子10~20份,远志10~20份,麦冬10~20份,天花粉10~20份,赤芍10~20份,仙茅10~20份。
所述提高免疫力的丹参口服液,其所述丹参保健茶中各种原料的重量份数也可以为:丹参10~40份,薏仁10~20份,当归10~20份,黄精10~20份,山茱萸10~20份,茯苓10~20份,丹参10~20份,党参10~20份,枸杞10~20份,制首乌10~20份,熟地10~15份,白术10~15份,五味子10~15份,女贞子10~15份,远志10~15份,麦冬10~15份,天花粉10~20份,赤芍10~20份,仙茅10~20份。
为解决上述技术问题,本发明还提供一种提高免疫力的丹参保健茶的制备方法,其所述丹参保健茶的制备步骤包括以下方面:
a.丹参的筛选、晾晒;
b.将晾好的丹参炒熟,泡入乙醇提取成浸膏,成组分1;
c.将所述其他原料浸泡乙醇加热提取成浸膏,为组分2;
d.再将上述两种组分合并,浓缩成糊状加蜂蜜或糊精调和后罐装。
所述步骤a中,可以在在9~10月采收成熟丹参果实,与寄主一同割下,晒干,打下种子,簸去杂质,洗净,晒干。
所述步骤b中,可以将晾晒好的丹参放入杀青锅中去青,在70-100℃下杀青30-45分钟,然后放入大铁锅内进行翻炒,开始翻炒20-30分钟,取出后自然阴凉;将晾晒好的丹参泡入10倍量乙醇中10-15天后,加热提取2次,每次1-2小时,去上清液,合并提取液,100-110目滤过,再经截流分子量为6000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时1.36的浸膏,加热浓缩至膏状,静置备用,成组分1。
所述步骤c中,可以取其他原料剩余原料泡入5-10倍量的乙醇中,浸泡1-2小时,加热提取2次,每次1-2小时,合并提取液,静置后去上清液,然后放入减压浓缩罐内,减压回收乙醇,浓缩至药液浓度为0.6g生药/mL,抽滤至滤液的相对密度为20℃时1.06的浸膏,成为组分2。
所述步骤d中,可以将上述步骤得到的浸膏置入双效真空浓缩器中,浓缩至90℃时相对密度为1.05的浓缩液,置0~5℃低温冷藏24小时;将冷藏液加0.3%的助滤剂硅藻土,过滤,滤液再置入双效真空浓缩器中,浓缩至每1ml含1g生药量;浓缩后的膏剂加蜂蜜调和制成口服液。
为解决上述技术问题,本发明再提供一种提高免疫力的丹参保健茶的制备方法,其制备步骤还可以为:
a.丹参的制备,作为组分1;
b.将所述其余原料药切碎提取作为组分2;
c.将组分1和组分2混合,浓缩后加适量蜂蜜调和,紫外线消毒杀菌后装瓶。
所述步骤b中,可以将其余原料药材混合,切碎过100~120目筛,过筛后细粉备用,粗颗粒放入耐酸碱浸渍锅,在室温下,与70度以上乙醇一起浸渍15~30天,然后加热回流提取2次,每次1~2小时,将2次提取液合并静置,过滤,分离后取滤液;用纱布过滤,残渣中加入50-60%乙醇,60℃-70℃继续浸提2h,每10min搅拌一次,纱布过滤,合并浸提液,浓缩成糊状成为组分2。
本发明有益的技术效果在于,丹参在《神农本草经》中被列为上品。其气味辛,甘,平无毒。功能与主治:补肾益精,养肝明目。适用于肝肾不足的腰膝筋骨酸痛,腿脚软弱无力、阳痿遗精、呓语、小便频数、尿有佘沥、头晕眼花、视物不清、耳鸣耳聋以及妇女带下、习惯性流产等症;再加上一些活血化瘀,健脾利湿养阴的中药材,这些药材大多口感清淡,不影响丹参茶的味道,没有难闻难以下咽的中药味,使人易于接受,可以明显提高免疫力,能较好的改善亚健康人群易感冒、眼睛酸涩、睡眠质量不高,脾虚乏力;食少口干;消渴;肾亏腰膝酸软;阳痿遗精;耳鸣目暗;须发早白;体虚赢瘦;风癞癣疾的症状,能较好的达到提高免疫力的功效。
具体实施方式
人体免疫是人体对外界的病原微生物等的防御机能,或者说是防御系统,在正常情况下,它能够保证人体不受外界病原微生物的侵害。通常说的人体免疫力就是指人体的免疫系统抵御外来病原微生物等侵害的能力。在人体免疫力正常的情况下,人体自身能够抵御相当多的病菌的侵害,避免对人体造成损伤。免疫力在人体生命机制中发挥重要的作用,而人体的营养、劳累、心情、环境、疾病、用药、辐射等导致自身的免疫力下降。越来越多研究表明,中药对人体免疫力的调节越来越发挥重要作用。
由于经济的日益发达,现代人生活水平的不断提升,致使人们过多的热爱享受,不注意自己的生活方式、行为习惯、饮食嗜好,从而引起的疾病。快节奏的社会生活,激烈竞争的工作压力,对现代人的身心健康造成了严重的威胁,使半数以上的人处于亚健康状态,表现为:头晕、心慌、乏力、食欲不振、记忆力减退、失眠、对事无兴趣等,加之,长期的饮食不合理,即:精粮完全取代粗粮,大量的三高(高热、高蛋白、高脂肪)、三多(防腐剂多、增味剂多、激素多)食物的摄入和食物中残留的农药、化肥在体内的存积,再加上空气、水源污染和运动量偏小,这样长期下去会使三高症(高血压、高血糖、高血脂)、心脑血管疾病、癌症等所谓的“现代文明病”急速上升,而且不断年轻化,严重的危害到人类的健康和生命。各种原因使免疫系统不能正常发挥保护作用,在此情况下,极易招致细菌、病毒、真菌等感染,因此免疫力低下最直接的表现就是容易生病。因经常患病,加重了机体的消耗,所以一般有体质虚弱、营养不良、精神萎靡、疲乏无力、食欲降低、睡眠障碍等表现,生病、打针吃药便成了家常便饭。每次生病都要很长时间才能恢复,而且常常反复发作。长此以往会导致身体和智力发育不良,还易诱发重大疾病。深层原因是免疫力低下或免疫力不健全。当人体免疫功能失调,或者免疫系统不健全时,下列问题就会反复发作:感冒反复发作、扁桃体炎反复发作、哮喘反复发作、支气管炎反复发作、肺炎反复发作、腹泻反复发作。所以千万不可小视。
丹参,中药名。为唇形科植物丹参SalviamiltiorrhizaBge.的干燥根和根茎。春、秋二季采挖,除去泥沙,干燥。全国大部分地区都有分布。具有活血祛瘀,通经止痛,清心除烦,凉血消痈之功效。用于胸痹心痛,脘腹胁痛,瘕瘕积聚,热痹疼痛,心烦不眠,月经不调,痛经经闭,疮疡肿痛。
多年生草本,高30~80厘米。根细长,圆柱形,外皮朱红色。茎四棱形,上部分枝。叶对生;单数羽状复叶,小叶3~5片。顶端小叶片较侧生叶片大,小叶片卵圆形。轮伞花序项生兼腋生,花唇形,蓝紫色,上唇直立,下唇较上唇短。小坚果长圆形,熟时暗棕色或黑色。花期5~10月,果期6~11月。
《本草纲目》:活血,通心包络,治疝痛。《本经》:心腹邪气,肠鸣幽幽如走水,寒热积聚,破症除瘕,止烦满,益气。《别录》:养血,去心腹痼疾结气,腰脊强脚痹,除风邪留热。久服利人。
茯苓味甘、淡、性平,入药具有利水渗湿、益脾和胃、宁心安神之功用。现代医学研究:茯苓能增强机体免疫功能,茯苓多糖有明显的抗肿瘤及保肝脏作用。茯苓性味甘淡平,入心、肺、脾经。具有渗湿利水,健脾和胃,宁心安神的功效。可治小便不利,水肿胀满,痰饮咳逆,呕逆,恶阻,泄泻,遗精,淋浊,惊悸,健忘等症。茯苓之利水,是通过健运脾肺功能而达到的,与其它直接利水的中药不同。用于脾虚泄泻,带下茯苓既能健脾,又能渗湿,对于脾虚运化失常所致泄泻、带下,应用茯苓有标本兼顾之效,常与党参、白术、山药等配伍。有可用为补肺脾,治气虚之辅佐药。
天花粉为葫芦科植物栝蒌的根,是一种中药,为清热泻火类药物,其具体功效是清热泻火,生津止渴,排脓消肿。主治:治热病口渴、消渴、黄疸、肺燥咳血、痈肿、痔痿。对于治疗糖尿病,常用它与滋阴药配合使用,以达到标本兼治的作用。《本草汇言》:天花粉,退五脏郁热,如心火盛而舌干口燥,肺火盛而咽肿喉痹,脾火盛而口舌齿肿,痰火盛而咳嗽不宁。若肝火之胁胀走注,肾火之骨蒸烦热,或痈疽已溃未溃,而热毒不散,或五疸身目俱黄,而小水若淋若涩,是皆火热郁结所致,惟此剂能开郁结,降痰火,并能治之。又其性甘寒,善能治渴,从补药而治虚渴,从凉药而治火渴,从气药而治郁渴,从血药而治烦渴,乃治渴之要药也。
白术味苦、甘,温。归脾、胃经。主治健脾益气,燥湿利水,止汗,安胎。用于脾虚食少,腹胀泄泻,痰饮眩悸,水肿,自汗,胎动不安。白术对瘤细胞有细胞毒作用,能降低瘤细胞的增殖率,减低瘤组织的侵袭性,提高机体抗肿瘤反应的能力。白术挥发油对小鼠艾氏腹水癌、淋巴肉瘤腹水型、食管癌(Ecal09)、肉瘤180等有抑制作用。白术内酯B腹腔注射对小鼠肉瘤民。也有显著抑制作用。《药性论》载其:君,味甘,辛,无毒。能主大风痹,多年气痢,心腹胀痛,破消宿食,开胃,去痰涎,除寒热,止下泄。主面光悦,驻颜,去黑。治水肿胀满,吐呕逆,腹内冷痛,吐泻不住,及胃气虚冷痢。
黄精以根茎入药。具有补气养阴,健脾,润肺,益肾功能。用于治疗脾胃虚弱,体倦乏力,口干食少,肺虚燥咳,精血不足,内热消渴等症。对于糖尿病很有疗效。酒黄精又称炙黄精。为净黄精加酒和黑豆等辅料蒸后切片晒干入药者。兼有遁经络之功。黄精具有降血压,降血糖,降血脂,防止动脉粥样硬化,延缓衰老和抗菌等作用,黄精多糖具有免疫激活作用。用于阴虚肺燥,干咳少痰,及肺肾阴虚的劳嗽久咳等。用于脾胃虚弱。既补脾阴,又益脾气,用于肾虚精亏得头晕,腰膝酸软,须发早白及消渴等。黄精壮筋骨,益精髓,变白发;适宜用于肺阴不足所致的咳嗽痰少,干咳无痰,咳血等症。
山茱萸味酸、涩性,微温。归肝、肾经。补益肝肾,涩精固脱。用于眩晕耳鸣,腰膝酸痛,阳痿遗精,遗尿尿频,崩漏带下,大汗虚脱,内热消渴,为固涩药,它含有山茱萸甙、莫罗甙、7-O-甲基莫罗甙、山茱萸新甙、当药甙、番木鳖甙等环烯醚萜甙类及皂甙、熊果酸、酒石酸、没食子酸、苹果酸、山茱萸鞣质1、2、3等多种有效成份。有明显的利尿、降脂、抗菌与升高血液白细胞的作用,对治疗肝肾亏损所致的眩晕耳鸣、腰酸等症及由于肾阴不足所致的遗精、尿频等症有明显疗效。又因其具有收敛止血功效被常用于妇女体虚所致的月经过多,崩漏带下等症,对男科、妇科的常见病均有很好的治疗作用,大量用于补益药物的生产,故被列为国药四十种大宗品种之一,在中医药界有着广泛的市场。
五味子温;酸、甘;归肺、心、肾经;收敛固涩,益气生津,补肾宁心。用于久嗽虚喘,梦遗滑精,遗尿尿频,久泻不止,自汗,盗汗,津伤口渴,短气脉虚,内热消渴,心悸失眠。《本草经疏》载:五味子主益气者,肺主诸气,酸能收,正入肺补肺,故益气也。其主咳逆上气者,气虚则上壅而不归元,酸以收之,摄气归元,则咳逆上气自除矣。劳伤赢瘦,补不足,强阴,益男子精。《别录》养五脏,除热,生阴中肌者,五味子专补肾,兼补五脏,肾藏精,精盛则阴强,收摄则真气归元,而丹田暖,腐熟水谷,蒸糟粕而化精微,则精自生,精生则阴长,故主如上诸疾也。
党参为中国常用的传统补益药,古代以山西上党地区出产的党参为上品,具有补中益气,健脾益肺之功效。现代研究,党参含多种糖类、酚类、甾醇、挥发油、黄芩素葡萄糖甙、皂甙及微量生物碱,具有增强免疫力、扩张血管、降压、改善微循环、增强造血功能等作用。此外对化疗放疗引起的白细胞下降有提升作用。党参具有补中益气,健脾益肺的功效。用于脾肺虚弱,气短心悸,食少便溏,虚喘咳嗽,内热消渴等。《本草从新》记载:“补中益气、和脾胃、除烦渴。中气微弱,用以调补,甚为平妥。”
中药何首乌有生首乌与制首乌之分,直接切片入药为生首乌,用黑豆煮汁拌蒸后晒干入药为制首乌。二者的功用有所不同:生首乌功能解毒、消痈、润肠通便,常用于治疗瘰疬疮痈、风疹瘙痒、肠燥便秘;制首乌功能补肝肾、益精血、乌须发、强筋骨,用于血虚萎黄、眩晕耳鸣、须发早白、腰膝酸软、肢体麻木、崩漏带下、久疟体虚等。本发明所采用的制首乌是补肾益肾的佳品。
当归,其味甘而重,故专能补血,其气轻而辛,故又能行血,补中有动,行中有补,诚血中之气药,亦血中之圣药。大约佐之以补则补,故能养营养血,补气生精,安五脏,强形体,益神志,凡有形虚损之病,无所不宜。佐之以攻则通,故能祛痛通便,利筋骨,治拘挛、瘫痪、燥、涩等证。营虚而表不解者,佐以柴、葛、麻、桂等剂,大能散表卫热,而表不敛者,佐以大黄之类,又能固表。惟其气辛而动,故欲其静者当避之,性滑善行,大便不固者当避之。凡阴中火盛者,当归能动血,亦非所宜,阴中阳虚者,当归能养血,乃不可少。
熟地又名熟地黄或伏地,属玄参科植物,是一种上好中药材,具有补血滋阴功效,可用于血虚萎黄,眩晕,心悸失眠,月经不调,崩漏等症,亦可用于肾阴不足的潮热骨蒸、盗汗、遗精、消渴等症,是虚证类非处方药药品六味地黄丸主要成分之一。本品质润入肾,善滋补肾阴,填精益髓,为补肾阴之要药。古人谓之“大补五脏真阴”,“大补真水”。常与山药、山茱萸等同用,治疗肝肾阴虚,腰膝酸软、遗精、盗汗、耳鸣、耳聋及消渴等,可补肝肾,益精髓,如六味地黄丸。
枸杞:甘,平。枸杞叶:苦、甘;性凉。功能:枸杞子:养肝,滋肾,润肺。枸杞叶:补虚益精,清热明目。枸杞多糖是一种水溶性多糖,是枸杞中最主要的活性成分,相对分子质量为68-200,成为国内外研究热点。其中又以枸杞多糖的免疫调节和抗肿瘤作用的研究最多。现已有很多研究表明枸杞多糖具有促进免疫、抗衰老、抗肿瘤、清除自由基、抗疲劳、抗辐射、保肝、生殖功能保护和改善等作用。
女贞子用于肝肾阴虚的目暗不明,视力减退,须发早白,腰酸耳鸣及阴虚发热等。本品能补肝肾阴,但药力平和,须缓慢取效。治目暗不明,常配熟地,枸杞等同用,治须发早白,常配桑葚同用,阴虚发热,常配地骨皮。肝肾阴虚,头昏目眩、遗精耳鸣、腰膝酸软,须发早白,冠心病、高脂血症、高血压、慢性肝炎。对肝脏的保护作用研究认为,女贞子含有齐墩果酸,给大鼠皮下注射,可降低血清谷丙转氨酶,对四氯化碳诱发的肝损伤有明显保护作用,并能促进肝细胞再生.齐墩果酸亦可使肝内甘油三酯蓄积减少、肝细胞变性坏死明显减轻、糖原蓄积增加、血清γ球蛋白下降;超微结构可见肝细胞内线粒体肿胀与内质网囊泡变性减轻、肝组织间质炎症反应减弱。
远志苦、辛,微温。归心、肾、肺经。功能主治安神益智,祛痰,消肿。用于心肾不交引起的失眠多梦,健忘惊悸,神志恍惚,咳痰不爽,疮疡肿毒,乳房肿痛。应用于失眠多梦,心悸怔忡,健忘。本品苦辛性温,性善宣泄通达,既能开心气而宁心安神、又能通肾气而强志不忘,为交通心肾、安定神志、益智强识之佳品。主治心肾不交之心神不宁、失眠、惊悸等症,常与茯神、龙齿、朱砂等镇静安神药同用,如远志丸(《张氏医通》);治健忘证,常与人参、茯苓、菖蒲同用,如开心散(《千金方》),若方中再加茯神,即不忘散(《证治准绳》)。《本草正》:远志,功专心肾,故可镇心止惊,辟邪安梦,壮阳益精,强志助力。以其气升,故同人参、甘草、枣仁,极能举陷摄精,交接水火。
麦冬性味功能:甘、微苦、凉、滋阴生津、润肺止咳、清心除烦。主治热病伤津、心烦、口渴、咽干肺热、咳嗽、肺结核。配沙参,肺胃同治,具有清肺凉胃,养阴生津之良好效用,用于阴虚肺燥或热伤肺阴所致的干咳少痰,咽喉干燥等症。配五味子,酸甘化阴,守阴所以留阳,阳留汗自止。功能养阴敛汗,用治阴虚汗多,心悸,肺虚久咳,少痰或痰粘不爽等。
赤芍苦,微寒。归肝经。主治功效:清热凉血;活血祛瘀。主温毒发斑;吐血衄血;肠风下血;目赤肿痛;痈肿疮疡;闭经;痛经;崩带淋浊;瘀滞胁痛;疝瘕积聚;跌扑损伤。用于温毒发斑,吐血衄血,目赤肿痛,肝郁胁痛,经闭痛经,症瘕腹痛,跌扑损伤,痈肿疮疡。《本经》:主邪气腹痛,除血痹,破坚积,寒热疝瘕,止痛,利小便,益气。《别录》:通顺血脉,缓中,散恶血,逐贼血,去水气,利膀胱大小肠,消痈肿,时行寒热,中恶腹痛,腰痛。《药性论》:治肺邪气,腹中疞痛,血气积聚,通宣脏腑拥气,治邪痛败血,主时疾骨热,强五脏,补肾气,治心腹坚胀,妇人血闭不通,消瘀血,能蚀脓。
仙茅具有补肾助阳、益精血、强筋骨和行血消肿的作用,主要用于肾阳不足、阳痿遗精、虚痨内伤和筋骨疼痛等病症。现代药理活性研究显示仙茅具有调节免疫、抗氧化、保肝、抗高血糖、补肾壮阳及抗骨质疏松、抗炎和适应原样等作用。
薏仁是常用的中药.又是普遍、常吃的食物,性味甘淡微寒,有利水消肿、健脾去湿、舒筋除痹、清热排脓等功效,为常用的利水渗湿药。薏仁又是一种美容食品,常食可以保持人体皮肤光泽细腻,消除粉刺、斑雀、老年斑、妊娠斑、蝴蝶斑,对脱屑、痤疮、皲裂、皮肤粗糙等都有良好疗效。薏米的种仁和根又能入药治病。李时珍在《本草纲目》中记载:薏米能″健脾益胃,补肺清热,去风胜湿。炊饭食,治冷气。煎饮,利小便热淋。″近年来,大量的科学研究和临床实践证明,薏米还是一种抗癌药物,初步鉴定,它对癌症的抑制率可达35%以上。
具体实施例1:
先将丹参筛选,晾晒;
再将丹参炒熟,泡入乙醇,提取,作为组分1;
再将其余原料薏仁,当归,黄精,山茱萸,茯苓,丹参,党参,枸杞,制首乌,熟地,白术,五味子,女贞子,远志,麦冬,天花粉,赤芍,仙茅提取,作为组分2;
将两种组分混合,加蜂蜜或糊精调和紫外线杀菌消毒装瓶。
具体实施例2:
在9~10月采收成熟丹参果实,与寄主一同割下,晒干,打下种子,簸去杂质,洗净,晒干。大约5000g,将晾晒好的丹参放入杀青锅中去青,在70-100℃下杀青30-45分钟,然后放入大铁锅内进行翻炒,开始翻炒20-30分钟,取出后自然阴凉;将晾晒好的丹参泡入10倍量乙醇中24小时后,加热提取2次,每次1-2小时,去上清液,合并提取液,100-110目滤过,再经截流分子量为6000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时1.36的浸膏,加热浓缩至膏状,静置备用,成组分1。
再取其他原料薏仁1500g,当归1500g,黄精1500g,山茱萸1500g,茯苓1500g,丹参1500g,党参1500g,枸杞1500g,制首乌1500g,熟地1500g,白术1500g,五味子1500g,女贞子1500g,远志1500g,麦冬1500g,天花粉1500g,赤芍1500g,仙茅1500g,加入5-10倍量的乙醇中浸泡24小时,加热提取2次,每次1-2小时,去上清液,合并提取液,100-120目滤过,再经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时1.36的浸膏,加热浓缩至膏状,静置备用,成组分2。
将两种组分置入双效真空浓缩器中,浓缩至90℃时相对密度为1.05的浓缩液,置0~5℃低温冷藏24小时;将冷藏液加0.3%的助滤剂硅藻土,过滤,滤液再置入双效真空浓缩器中,浓缩至每1ml含1g生药量,然后加蜂蜜调和,成口服液。
具体实施例3:
在9~10月采收成熟丹参果实,与寄主一同割下,晒干,打下种子,簸去杂质,洗净,晒干。大约4000g,将晾晒好的丹参泡入10倍量乙醇中24小时后,加热提取2次,每次1-2小时,去上清液,合并提取液,100-110目滤过,再经截流分子量为6000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时1.36的浸膏,加热浓缩至膏状,静置备用,成组分1;取其他原料薏仁1200g,当归1300g,黄精1200g,山茱萸1100g,茯苓1200g,丹参1200g,党参1200g,枸杞1200g,制首乌1100g,熟地1200g,白术1200g,五味子1200g,女贞子1200g,远志1200g,麦冬1100g,天花粉1200g,赤芍1200g,仙茅1200g,取原料药洗净晾干;浸泡水中12小时,然后放入提取罐加热煮沸1小时,过滤,滤液备用;滤渣加水,第二次加热,煮沸45分钟,过滤,滤液备用;滤渣再加水,第三次加热煮沸半小时,过滤;将三次滤液合在一起,粉末置于70-90%乙醇中浸泡1-2小时,在水浴锅内加热到60℃-70℃,浸提2h,每10min搅拌一次,用纱布过滤,残渣中加入50-60%乙醇,60℃-70℃继续浸提2h,每10min搅拌一次,纱布过滤,合并浸提液,浓缩成糊状,成组分2;将组分1和组分2混合。然后加蜂蜜调和,制成口服液;紫外线灭菌,包装即得。
具体实施例4:
在9~10月采收成熟丹参果实,与寄主一同割下,晒干,打下种子,簸去杂质,洗净,晒干。大约3500g,再取其他原料薏仁1200g,当归1300g,黄精1200g,山茱萸1100g,茯苓1200g,丹参1200g,党参1200g,枸杞1200g,制首乌1100g,熟地1200g,白术1200g,五味子1200g,女贞子1200g,远志1200g,麦冬1100g,天花粉1200g,赤芍1200g,仙茅1200g,将所有原料放入10倍量乙醇中,加热回流提取2次,每次1~2小时,将2次提取液合并静置;再将上述乙醇提取过的组份原料药材的药渣加10倍量水加热回流提取2次,每次1~2小时,将2次提取液合并静置;将上述两种提取液合并,减压浓缩相对密度为1.35(80℃)的滤液,回收乙醇,将所得滤液调整比重到1.06,减压得浸膏,然后加蜂蜜调和,城口服液,紫外线灭菌,包装即得。
Claims (10)
1.一种提高免疫力的丹参口服液,其特征在于,所述丹参保健茶中各种原料的重量份数包括:丹参10~50份,薏仁10~20份,当归10~20份,黄精10~20份,山茱萸10~20份,茯苓10~20份,丹参10~20份,党参10~20份,枸杞10~20份,制首乌10~20份,熟地10~20份,白术10~20份,五味子10~20份,女贞子10~20份,远志10~20份,麦冬10~20份,天花粉10~20份,赤芍10~20份,仙茅10~20份。
2.根据权利要求1所述提高免疫力的丹参口服液,其特征在于,所述丹参保健茶中各种原料的重量份数包括:丹参10~30份,薏仁10~15份,当归10~15份,黄精10~15份,山茱萸10~15份,茯苓10~15份,丹参10~15份,党参10~15份,枸杞10~15份,制首乌10~15份,熟地10~20份,白术10~20份,五味子10~20份,女贞子10~20份,远志10~20份,麦冬10~20份,天花粉10~20份,赤芍10~20份,仙茅10~20份。
3.根据权利要求1所述提高免疫力的丹参口服液,其特征在于,所述丹参保健茶中各种原料的重量份数包括:丹参10~40份,薏仁10~20份,当归10~20份,黄精10~20份,山茱萸10~20份,茯苓10~20份,丹参10~20份,党参10~20份,枸杞10~20份,制首乌10~20份,熟地10~15份,白术10~15份,五味子10~15份,女贞子10~15份,远志10~15份,麦冬10~15份,天花粉10~20份,赤芍10~20份,仙茅10~20份。
4.一种如权利要求1~3项任一项所述提高免疫力的丹参保健茶的制备方法,其特征在于,所述丹参保健茶的制备步骤包括以下方面:
a.丹参的筛选、晾晒;
b.将晾好的丹参炒熟,泡入乙醇提取成浸膏,成组分1;
c.将所述其他原料浸泡乙醇加热提取成浸膏,为组分2;
d.再将上述两种组分合并,浓缩成糊状加蜂蜜或糊精调和后罐装。
5.根据权利要求4所述提高免疫力的丹参口服液的制备方法,其特征在于,所述步骤a中,在9~10月采收成熟丹参果实,与寄主一同割下,晒干,打下种子,簸去杂质,洗净,晒干。
6.根据权利要求4所述提高免疫力的丹参口服液的制备方法,其特征在于,所述步骤b中,将晾晒好的丹参放入杀青锅中去青,在70-100℃下杀青30-45分钟,然后放入大铁锅内进行翻炒,开始翻炒20-30分钟,取出后自然阴凉;将晾晒好的丹参泡入10倍量乙醇中24小时后,加热提取2次,每次1-2小时,去上清液,合并提取液,100-110目滤过,再经截流分子量为6000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时1.36的浸膏,加热浓缩至膏状,静置备用,成组分1。
7.根据权利要求4所述提高免疫力的丹参口服液的制备方法,其特征在于,所述步骤c中,取其他原料剩余原料泡入5-10倍量的乙醇中,浸泡24小时,加热提取2次,每次1-2小时,合并提取液,静置后去上清液,然后放入减压浓缩罐内,减压回收乙醇,浓缩至药液浓度为0.6g生药/mL,抽滤至滤液的相对密度为20℃时1.06的浸膏,成为组分2。
8.根据权利要求4所述提高免疫力的丹参口服液制备方法,其特征在于,所述步骤d中,将上述步骤得到的浸膏置入双效真空浓缩器中,浓缩至90℃时相对密度为1.05的浓缩液,置0~5℃低温冷藏24小时;将冷藏液加0.3%的助滤剂硅藻土,过滤,滤液再置入双效真空浓缩器中,浓缩至每1ml含1g生药量;浓缩后的膏剂加蜂蜜调和制成口服液。
9.一种如权利要求1~3中任一项所述提高免疫力的丹参口服液的制备方法,其特征在于,其制备步骤还可以为:
a.丹参的制备,作为组分1;
b.将所述其余原料药切碎提取作为组分2;
c.将组分1和组分2混合,浓缩后加适量蜂蜜调和,紫外线消毒杀菌后装瓶。
10.根据权利要求9所述提高免疫力的丹参口服液的制备方法,其特征在于,所述步骤b中,将其余原料药材混合,切碎过100~120目筛,过筛后细粉备用,粗颗粒放入耐酸碱浸渍锅,在室温下,与70度以上乙醇一起浸渍15~30天,然后加热回流提取2次,每次1~2小时,将2次提取液合并静置,过滤,分离后取滤液;用纱布过滤,残渣中加入50-60%乙醇,60℃-70℃继续浸提2h,每10min搅拌一次,纱布过滤,合并浸提液,浓缩成糊状成为组分2。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510855905.1A CN105341944A (zh) | 2015-11-28 | 2015-11-28 | 一种提高免疫力的丹参口服液及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510855905.1A CN105341944A (zh) | 2015-11-28 | 2015-11-28 | 一种提高免疫力的丹参口服液及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105341944A true CN105341944A (zh) | 2016-02-24 |
Family
ID=55318222
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510855905.1A Pending CN105341944A (zh) | 2015-11-28 | 2015-11-28 | 一种提高免疫力的丹参口服液及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105341944A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106174483A (zh) * | 2016-07-10 | 2016-12-07 | 马佳 | 一种提高免疫力的仙茅口服液及其制备方法 |
CN106174561A (zh) * | 2016-07-10 | 2016-12-07 | 马佳 | 提高免疫力的仙茅口服液制备方法及其口服液 |
CN110170001A (zh) * | 2019-06-26 | 2019-08-27 | 北京采瑞医药科技有限公司 | 具有增强免疫力功效的蚁蜂口服液及其制备方法 |
-
2015
- 2015-11-28 CN CN201510855905.1A patent/CN105341944A/zh active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106174483A (zh) * | 2016-07-10 | 2016-12-07 | 马佳 | 一种提高免疫力的仙茅口服液及其制备方法 |
CN106174561A (zh) * | 2016-07-10 | 2016-12-07 | 马佳 | 提高免疫力的仙茅口服液制备方法及其口服液 |
CN110170001A (zh) * | 2019-06-26 | 2019-08-27 | 北京采瑞医药科技有限公司 | 具有增强免疫力功效的蚁蜂口服液及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102988638B (zh) | 一种青钱柳叶降脂降糖保健茶及其制备方法 | |
CN104435775B (zh) | 一种中药保健酒及其制备方法 | |
CN103007035B (zh) | 一种清肝明目的枸杞叶中药茶饮及其制备方法 | |
CN104305205B (zh) | 一种提高免疫力的菟丝子口服液及其制备方法 | |
CN103005104B (zh) | 一种防治肺肾阴虚的枸杞叶中药养生茶及其制备方法 | |
CN103734424A (zh) | 一种苦荞减肥降脂通便茶及其制备方法 | |
CN103719494A (zh) | 一种牛蒡子通便润肠保健茶及其制备方法 | |
CN104365943A (zh) | 一种降糖降脂的槐角茶及其制备方法 | |
CN103749821B (zh) | 一种提高免疫力的绞股蓝保健茶及其制备方法 | |
CN103735835A (zh) | 一种治疗少白头的中药制剂及其制备方法 | |
CN104472789A (zh) | 一种润肠通便的槐角茶及其制备方法 | |
CN103749824A (zh) | 一种绞股蓝降糖降压保健茶及其制备方法 | |
CN105341944A (zh) | 一种提高免疫力的丹参口服液及其制备方法 | |
CN104304602A (zh) | 一种软化血管的槐角茶及其制备方法 | |
CN103783508A (zh) | 一种苦荞美容祛斑口服液及其制备方法 | |
CN105394282A (zh) | 一种可降压降糖降脂的葛根保健茶 | |
CN105343593A (zh) | 一种降压降脂的夏枯草保健口服液及其制备方法 | |
CN105341226A (zh) | 一种具有通便润肠功效的保健茶及其制备方法 | |
CN104397282A (zh) | 一种安神补脑的刺五加保健茶及其制备方法 | |
CN105343502A (zh) | 一种可提高免疫力的保健口服液 | |
CN105410268A (zh) | 一种明目降脂的菟丝子保健茶及其制备方法 | |
CN105455125A (zh) | 一种提高免疫力的龙眼肉口服液及其制备方法 | |
CN105381220A (zh) | 一种明目降脂的菟丝子保健茶 | |
CN105213999A (zh) | 一种温经止痛的丹参叶保健茶及其制备方法 | |
CN109646665A (zh) | 杜仲清肺抗癌固体茶及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160224 |
|
WD01 | Invention patent application deemed withdrawn after publication |